Perioperative Antibiotic Stewardship in the Organ Transplant Setting

Overview

Journal Transpl Infect Dis

Specialties General Surgery
Infectious Diseases

Date 2022 Jul 5

PMID 35781915

Authors

Elena Graziano

Maddalena Peghin

Paolo Antonio Grossi

Affiliations

Soon will be listed here.

Abstract

Background: Solid organ transplant (SOT) recipients can benefit from traditional antimicrobial stewardship (AMS) activities directed to improve judicious perioperative prescribing and management, but evidence is lacking. The aim of this expert opinion review is to provide an update on the current landscape of application of AMS practices for optimization of perioperative prophylaxis (PP).

Methods: We reviewed the available literature on early postoperative infectious complications in SOT and PP management, on modified perioperative approaches in case of infection or colonization in recipients and donors and on AMS in transplantation PP.

Results: SOT recipients are at high risk for early postoperative infectious complications due to the complexity of surgical procedures, severity of end stage organ disease, net state of immunosuppression in the posttransplant period and to the high risk for multidrug resistant organism. Moreover, SOT may be exposed to preservation fluid infections and expected or unexpected donor-derived infections. We summarize main factors to take into account when prescribing transplant PP.

Conclusion: Creating personalized PP to avoid unwanted consequences of antimicrobials while improving outcomes is an emerging and critical aspect in SOT setting. Further studies are needed to offer best PP tailored to SOT type and to evaluate interventions efficacy and safety.

Citing Articles

Assessment of Current Practices for Perioperative Antibiotic Prophylaxis in Kidney Transplantation in China: Results from a Nationwide Survey.

Hou W, Yang J, Ma K, Liu X, Yang H, Qian Q Infect Drug Resist. 2024; 17:5469-5479.

PMID: 39676849 PMC: 11646463. DOI: 10.2147/IDR.S480788.

Non-Standard Risk Donors and Risk of Donor-Derived Infections: From Evaluation to Therapeutic Management.

Grossi P, Wolfe C, Peghin M Transpl Int. 2024; 37:12803.

PMID: 39416809 PMC: 11479921. DOI: 10.3389/ti.2024.12803.

Incidence, risk factors and clinical outcome of multidrug-resistant organisms after heart transplantation.

Hatzianastasiou S, Vlachos P, Stravopodis G, Elaiopoulos D, Koukousli A, Papaparaskevas J World J Transplant. 2024; 14(2):93567.

PMID: 38947964 PMC: 11212582. DOI: 10.5500/wjt.v14.i2.93567.

Surgical Antibiotic Prophylaxis: A Proposal for a Global Evidence-Based Bundle.

Sartelli M, Coccolini F, Labricciosa F, Al Omari A, Bains L, Baraket O Antibiotics (Basel). 2024; 13(1).

PMID: 38275329 PMC: 10812782. DOI: 10.3390/antibiotics13010100.

Six Long-Standing Questions about Antibiotic Prophylaxis in Surgery.

Sartelli M, Boermeester M, Cainzos M, Coccolini F, de Jonge S, Rasa K Antibiotics (Basel). 2023; 12(5).

PMID: 37237811 PMC: 10215114. DOI: 10.3390/antibiotics12050908.

References

Howell C, Paciullo C, Lyon G, Neujahr D, Lyu P, Cotsonis G . Effect of positive perioperative donor and recipient respiratory bacterial cultures on early post-transplant outcomes in lung transplant recipients. Transpl Infect Dis. 2017; 19(6). DOI: 10.1111/tid.12760. View

Bouza E, Munoz P, Burillo A . Role of the Clinical Microbiology Laboratory in Antimicrobial Stewardship. Med Clin North Am. 2018; 102(5):883-898. DOI: 10.1016/j.mcna.2018.05.003. View

Silva J, San-Juan R, Fernandez-Caamano B, Prieto-Bozano G, Fernandez-Ruiz M, Lumbreras C . Infectious Complications Following Small Bowel Transplantation. Am J Transplant. 2015; 16(3):951-9. DOI: 10.1111/ajt.13535. View

Malinis M, Boucher H . Screening of donor and candidate prior to solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33(9):e13548. DOI: 10.1111/ctr.13548. View

Camargo L, Marra A, Pignatari A, Sukiennik T, Behar P, Medeiros E . Nosocomial bloodstream infections in a nationwide study: comparison between solid organ transplant patients and the general population. Transpl Infect Dis. 2015; 17(2):308-13. DOI: 10.1111/tid.12356. View

Anesi J, Blumberg E, Abbo L . Perioperative Antibiotic Prophylaxis to Prevent Surgical Site Infections in Solid Organ Transplantation. Transplantation. 2017; 102(1):21-34. DOI: 10.1097/TP.0000000000001848. View

Moghnieh R, Awad L, Abdallah D, Jadayel M, Sinno L, Tamim H . Effect of a "handshake" stewardship program versus a formulary restriction policy on High-End antibiotic use, expenditure, antibiotic resistance, and patient outcome. J Chemother. 2020; 32(7):368-384. DOI: 10.1080/1120009X.2020.1755589. View

Pfundstein J, Roghmann M, Schwalbe R, Qaiyumi S, McCarter Jr R, Keay S . A randomized trial of surgical antimicrobial prophylaxis with and without vancomycin in organ transplant patients. Clin Transplant. 1999; 13(3):245-52. DOI: 10.1034/j.1399-0012.1999.130305.x. View

Hand J, Patel G . Antimicrobial stewardship in transplant patients. Curr Opin Organ Transplant. 2019; 24(4):497-503. DOI: 10.1097/MOT.0000000000000661. View

10.

Abbo L, Grossi P . Surgical site infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33(9):e13589. DOI: 10.1111/ctr.13589. View

11.

Wolfe C, Ison M . Donor-derived infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33(9):e13547. DOI: 10.1111/ctr.13547. View

12.

So M, Yang D, Bell C, Humar A, Morris A, Husain S . Solid organ transplant patients: are there opportunities for antimicrobial stewardship?. Clin Transplant. 2016; 30(6):659-68. DOI: 10.1111/ctr.12733. View

13.

Freire M, Song A, Oshiro I, Andraus W, Carneiro DAlbuquerque L, Abdala E . Surgical site infection after liver transplantation in the era of multidrug-resistant bacteria: what new risks should be considered?. Diagn Microbiol Infect Dis. 2020; 99(1):115220. DOI: 10.1016/j.diagmicrobio.2020.115220. View

14.

Mularoni A, Bertani A, Vizzini G, Gona F, Campanella M, Spada M . Outcome of Transplantation Using Organs From Donors Infected or Colonized With Carbapenem-Resistant Gram-Negative Bacteria. Am J Transplant. 2015; 15(10):2674-82. DOI: 10.1111/ajt.13317. View

15.

Lubbert C, Faucheux S, Becker-Rux D, Laudi S, Durrbeck A, Busch T . Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience. Int J Antimicrob Agents. 2013; 42(6):565-70. DOI: 10.1016/j.ijantimicag.2013.08.008. View

16.

Bunsow E, Los-Arcos I, Martin-Gomez M, Bello I, Pont T, Berastegui C . Donor-derived bacterial infections in lung transplant recipients in the era of multidrug resistance. J Infect. 2019; 80(2):190-196. DOI: 10.1016/j.jinf.2019.12.006. View

17.

Shaikh S, Zimmerman A, Nolan A, Cooper M, Abrams P . The incidence of fungal infections in pancreas transplant recipients in the absence of systemic antifungal prophylaxis. Clin Transplant. 2019; 33(10):e13691. DOI: 10.1111/ctr.13691. View

18.

Bertrand D, Pallet N, Sartorius A, Zahar J, Sberro Soussan R, Lortholary O . Clinical and microbial impact of screening kidney allograft preservative solution for bacterial contamination with high-sensitivity methods. Transpl Int. 2013; 26(8):795-9. DOI: 10.1111/tri.12130. View

19.

Coiffard B, Prudhomme E, Hraiech S, Cassir N, Le Pavec J, Kessler R . Worldwide clinical practices in perioperative antibiotic therapy for lung transplantation. BMC Pulm Med. 2020; 20(1):109. PMC: 7191774. DOI: 10.1186/s12890-020-1151-9. View

20.

Lanini S, Costa A, Puro V, Procaccio F, Grossi P, Vespasiano F . Incidence of carbapenem-resistant gram negatives in Italian transplant recipients: a nationwide surveillance study. PLoS One. 2015; 10(4):e0123706. PMC: 4383484. DOI: 10.1371/journal.pone.0123706. View